Diaceutics PLC (AIM:DXRX)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 202.75
-1.25 (-0.61%)
Nov 6, 2026, 4:10 PM GMT
Diaceutics Financials Overview
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 41.33 | 38.44 | 32.16 | 23.7 | 19.5 | 13.94 |
Revenue Growth | 7.52% | 19.53% | 35.69% | 21.51% | 39.88% | 9.82% |
Gross Profit Gross Profit Growth | 34.25 | 31.48 | 28.27 | 19.71 | 16.74 | 12.23 |
Operating Income Operating Income Growth | -0.79 | 0.04 | -2.46 | -3.02 | 0.58 | 0.55 |
Net Income Net Income Growth | -0.27 | 0.1 | -1.7 | -1.75 | 0.72 | 0.56 |
Earnings Per Share EPS Growth | -0.00 | 0.00 | -0.02 | -0.02 | 0.01 | 0.01 |
EPS Growth | - | - | - | - | 27.29% | 94.55% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
North America North America Growth | 38.76 | 35.85 | 29.54 | 20.83 | 14.45 | 8.46 |
UK UK Growth | 0.37 | 0.77 | 0.55 | 0.35 | 0.56 | 0.56 |
Europe Europe Growth | 2.08 | 1.79 | 1.89 | 2.47 | 2.7 | 3.62 |
Asia and Rest of World Asia and Rest of World Growth | 0.12 | 0.03 | 0.18 | 0.05 | 1.79 | 1.31 |
Total Total Growth | 41.33 | 38.44 | 32.16 | 23.7 | 19.5 | 13.94 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 8.1 | 7.34 | 12.74 | 16.67 | 19.84 | 19.68 |
Total Debt Total Debt Growth | 2.09 | 1.15 | 1.06 | 1.21 | 1.33 | 1.56 |
Net Cash (Debt) Net Cash Growth | 6.01 | 6.19 | 11.68 | 15.46 | 18.51 | 18.11 |
Net Cash Growth | -2.97% | -47.00% | -24.43% | -16.48% | 2.20% | -27.94% |
Net Cash Per Share Net Cash Per Share Growth | 0.07 | 0.07 | 0.14 | 0.18 | 0.22 | 0.21 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 3.92 | 1.18 | 0.65 | 1.31 | 5.1 | 0.57 |
Capital Expenditures CapEx Growth | -0.04 | -0.07 | -0.1 | -0.13 | -0.19 | -0.57 |
Free Cash Flow Free Cash Flow Growth | 3.89 | 1.11 | 0.55 | 1.19 | 4.91 | 0.01 |
Free Cash Flow Growth | 250.72% | 101.09% | -53.54% | -75.84% | 98100.00% | -95.69% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 82.88% | 81.90% | 87.91% | 83.15% | 85.83% | 87.73% |
Operating Margin | -1.92% | 0.11% | -7.63% | -12.73% | 2.95% | 3.94% |
Pretax Margin | -1.58% | 0.79% | -5.93% | -10.29% | 2.89% | 3.31% |
Profit Margin | -0.66% | 0.25% | -5.30% | -7.37% | 3.71% | 4.02% |
FCF Margin | 9.40% | 2.88% | 1.71% | 5.00% | 25.17% | 0.04% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 1120.49 | - | - | 87.95 | 152.85 |
Forward PE | 234.78 | 49.23 | 24.77 | 24.77 | 30.32 | 40.80 |
P/FCF Ratio | 44.29 | 98.09 | 192.50 | 61.82 | 12.97 | 17150.06 |
PS Ratio | 4.16 | 2.83 | 3.30 | 3.09 | 3.27 | 6.15 |